Thymofox - Crunchbase Company Profile & Funding

Overview

Thymofox

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Thymofox

CB Rank

3587473

Thymofox is developing targeted, orally available medicines for thymus regeneration – unlocking the power of the adaptive immune system.

Founded

obfuscation

Private

11-50

www.thymofox.com

Biotechnology

Key People

Christopher Shepard: CEO, Board of Directors & Co-Founder
Past Role: SmartZyme BioPharma, GM/Chief Executive

Details

Operating Status

Active

Founders

Christopher Shepard

Predictions & Insights

Growth Prediction

See this Growth Prediction

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Market Intelligence

People

View Profiles & Contacts

Headcount

11-50

Employee Profiles

Christopher Shepard CEO, Board of Directors & Co-Founder

News

Technology

View Tech Report

Lists Featuring This Company

Carnegie Mellon University - The Tepper School of Business Alumni Founded Companies

265 Number of Organizations • $6.9B Total Funding Amount • 497 Number of Investors

Sub-Organizations

Frequently Asked Questions